Impact of Peritumoral Edema During Tumor Treatment Field Therapy: A Computational Modelling Study

Background: Tumor treatment fields (TTFie-lds) are an approved adjuvant therapy for glioblastoma (GBM). The magnitude of applied electrical field has been shown to be related to the anti-tumoral response. However, peritumoral edema may result in shunting of electrical current around the tumor, thereby reducing the intra-tumoral electric field. In this study, we systematically address this issue with computational simulations. Methods: Finite element models are created of a human head with varying amounts of peritumoral edema surrounding a virtual tumor. The electric field distribution was simulated using the standard TTFields electrode montage. Electric field magnitude was extracted from the tumor and related to edema thickness. Two patient specific models were created to confirm these results. Results: The inclusion of peritumoral edema decreased the average magnitude of the electric field within the tumor. In the model considering a frontal tumor and an anterior-posterior electrode configuration, ≥6 mm of peritumoral edema decreased the electric field by 52%. In the patient specific models, peritumoral edema decreased the electric field magnitude within the tumor by an average of 26%. The effect of peritumoral edema on the electric field distribution was spatially heterogenous, being most significant at the tissue interface between edema and tumor. Conclusions: The inclusion of peritumoral edema during TTFields modelling may have a dramatic effect on the predicted electric field magnitude within the tumor. Given the importance of electric field magnitude for the anti-tumoral effects of TTFields, the presence of edema should be considered both in future modelling studies and when planning TTField therapy.

[1]  Lucas C. Parra,et al.  Realistic volumetric-approach to simulate transcranial electric stimulation—ROAST—a fully automated open-source pipeline , 2017, bioRxiv.

[2]  J. Vymazal,et al.  Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields) , 2009, BMC medical physics.

[3]  P. Ciechanski,et al.  Modeling Transcranial Direct-Current Stimulation-Induced Electric Fields in Children and Adults , 2018, Front. Hum. Neurosci..

[4]  H. Eskola,et al.  The Resistivity of Human Brain Tumours In Vivo , 2019, Annals of Biomedical Engineering.

[5]  J. Lindemeyer,et al.  An MR technique for simultaneous quantitative imaging of water content, conductivity and susceptibility, with application to brain tumours using a 3T hybrid MR-PET scanner , 2019, Scientific Reports.

[6]  Walter Stummer,et al.  Mechanisms of tumor-related brain edema. , 2007, Neurosurgical focus.

[7]  V. Rajshekhar Continuous impedance monitoring during CT-guided stereotactic surgery: relative value in cystic and solid lesions. , 1992, British journal of neurosurgery.

[8]  David A. Boas,et al.  Tetrahedral mesh generation from volumetric binary and grayscale images , 2009, 2009 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[9]  A. Vescovi,et al.  Cancer stem cells from peritumoral tissue of glioblastoma multiforme: the possible missing link between tumor development and progression , 2018, Oncotarget.

[10]  Peng Wen,et al.  Assessment of electric field distribution in anisotropic cortical and subcortical regions under the influence of tDCS , 2014, Bioelectromagnetics.

[11]  Thomas C. Chen,et al.  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. , 2015, JAMA.

[12]  Axel Thielscher,et al.  Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations , 2018, PloS one.

[13]  Edwin Lok,et al.  Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations , 2015, Expert review of medical devices.

[14]  Axel Thielscher,et al.  Estimating the Intensity and Anisotropy of Tumor Treating Fields Jsing Singular Value Decomposition. Towards a More Comprehensive Estimation of Anti-tumor Efficacy , 2018, 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[15]  Kevin Petrecca,et al.  Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma , 2012, Journal of Neuro-Oncology.

[16]  T. Cloughesy,et al.  Probabilistic Radiographic Atlas of Glioblastoma Phenotypes , 2013, American Journal of Neuroradiology.

[17]  L. Parra,et al.  Measurements and models of electric fields in the in vivo human brain during transcranial electric stimulation , 2017, Brain Stimulation.

[18]  K. Plate,et al.  Dexamethasone-induced leukocytosis is associated with poor survival in newly diagnosed glioblastoma , 2018, Journal of Neuro-Oncology.

[19]  A. Thielscher,et al.  Optimization of tumor treating fields using singular value decomposition and minimization of field anisotropy , 2019, Physics in medicine and biology.

[20]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[21]  P. Basser,et al.  Predicting the electric field distribution in the brain for the treatment of glioblastoma , 2014, Physics in medicine and biology.

[22]  H. Shirato,et al.  Noninvasive electrical conductivity measurement by MRI: a test of its validity and the electrical conductivity characteristics of glioma , 2017, European Radiology.

[23]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[24]  S. Toms,et al.  Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial , 2018, Journal of Neuro-Oncology.

[25]  F. Lieberman,et al.  Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial , 2017, JAMA.

[26]  Yoram Palti,et al.  NovoTTF™-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL™ system user study , 2015, World Journal of Surgical Oncology.

[27]  E. Wong,et al.  Tumor Treating Fields Perturb the Localization of Septins and Cause Aberrant Mitotic Exit , 2015, PloS one.

[28]  E. Dekel,et al.  Disruption of cancer cell replication by alternating electric fields. , 2004, Cancer research.

[29]  S. Toms,et al.  Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial. , 2019, International journal of radiation oncology, biology, physics.

[30]  E. Dekel,et al.  Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors , 2007, Proceedings of the National Academy of Sciences.

[31]  C. Almli,et al.  Unbiased nonlinear average age-appropriate brain templates from birth to adulthood , 2009, NeuroImage.

[32]  Christophe Geuzaine,et al.  A general environment for the treatment of discrete problems and its application to the finite element method , 1998 .

[33]  S. Bauer,et al.  Multi-Modal Glioblastoma Segmentation: Man versus Machine , 2014, PloS one.

[34]  D. Damek,et al.  A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma , 2016, CNS oncology.

[35]  Zhi-Xiong Lin,et al.  Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma , 2015, World Journal of Surgical Oncology.

[36]  D. B. Heppner,et al.  Considerations of quasi-stationarity in electrophysiological systems. , 1967, The Bulletin of mathematical biophysics.

[37]  Ricardo Salvador,et al.  The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study , 2015, Physics in medicine and biology.

[38]  A. Thielscher,et al.  A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling , 2018, IEEE Reviews in Biomedical Engineering.

[39]  A. Thielscher,et al.  Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study , 2017, PloS one.

[40]  A. Thielscher,et al.  Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study , 2016, PloS one.